PARP/EZH2-IN-1 is a first-in-class dual PARP ( IC 50 6.87 nM) and EZH2 ( IC 50 36.51 nM) inhibitor for triple-negative breast cancer with wild-type BRCA.

2687273-52-3

C43H41FN8O5

768.85

PARP/EZH2-IN-1

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years